Cyano Single Bonded And Nitrogen Or Phosphorus Double Bonded To The Same Carbon Atom (e.g., Alpha-imino Nitriles, Etc.) Patents (Class 558/300)
-
Patent number: 11555011Abstract: Process for the production of methylidene malonates and cyanoacrylates employing in-situ formed iminium salts derived from acid halides and/or acid anhydrides and N,N,N?,N?-tetra hydrocarbyl diaminoalkanes, the acid halides and/or acid anhydrides being present in a molar excess relative to the diaminoalkanes, as co-reactants with select malonic acid esters and cyanoacetates, respectively.Type: GrantFiled: March 23, 2020Date of Patent: January 17, 2023Assignee: H.B. Fuller CompanyInventors: Vijaya Bhasker Gondi, John Gregory Reid
-
Publication number: 20150044122Abstract: A device and a method are provided for reacting a starting material in at least two reactors connected to each other, including the reacting of the starting material in a first reactor to a first product, removing the first product from the first reactor using a jet pump, wherein a negative pressure zone of the jet pump is operationally connected to the first reactor, so that the first product of the first reactor moves through the negative pressure zone in a propulsion jet of a propulsion medium of the jet pump, conducting the propulsion medium having the first product into a second reactor, wherein the first product is allowed to react into a second product, separating the second product from the propulsion medium and discharging the separated second product.Type: ApplicationFiled: March 19, 2013Publication date: February 12, 2015Inventors: Stefan Zikeli, Friedrich Ecker
-
Publication number: 20130040395Abstract: The present invention relates to the use of a halogenated cyanocinnamic acid derivative with the general formula: wherein R is selected independently among F, Cl and Br, n=3, 4 or 5 and R? is selected among COOH, CONH2, SO3H and COOR? with R?=C1-O5-Alkyl; and/or of 4-bromo-?-cyanocinnamic acid and/or of ?-cyano-2,4-dichlorocinnamic acid in a matrix for a MALDI mass spectrometry of an analyte.Type: ApplicationFiled: March 2, 2011Publication date: February 14, 2013Applicant: JOHANN WOLFGANG GOETHE-UNIVERSITÄTInventors: Thorsten Jaskolla, Michael Karas
-
Publication number: 20110112166Abstract: Compounds comprising formula (I) or a pharmaceutically acceptable salt thereof, are disclosed, wherein B, Y, and A are as described in claims 1-10. Methods, compositions, and medicaments related thereto are also disclosed, for treating baldness, glaucoma or inflammatory bowel diseases.Type: ApplicationFiled: May 4, 2009Publication date: May 12, 2011Applicant: ALLERGAN, INCInventors: Yariv Donde, Jeremiah H. Nguyen
-
Patent number: 7393961Abstract: (Per)haloethers having formula: X-(Rf)L-O—CF2CF2—O—CX1X2—CFX3X4 , ??(I) process for obtaining them and hypofluorites usable in the synthesis of said (per)haloethers.Type: GrantFiled: March 8, 2005Date of Patent: July 1, 2008Assignee: Solvay Solexis S.p.A.Inventors: Giovanni Fontana, Walter Navarrini
-
Patent number: 7115755Abstract: The invention relates to new reactive mesogenic azulene derivatives, their use as semiconductors or charge transport materials, in optical, electro-optical or electronic devices like for example liquid crystal displays, optical films, organic field effect transistors (FET or OFET) for thin film transistor liquid crystal displays and integrated circuit devices such as RFID tags, electroluminescent devices in flat panel displays, and in photovoltaic and sensor devices, and to a field effect transistor, light emitting device or ID tag comprising the reactive mesogenic azulenes.Type: GrantFiled: December 9, 2002Date of Patent: October 3, 2006Assignee: Merck Patent GmbHInventors: Louise Diane Farrand, Michael Findlater, Mark Giles, Martin Heeney, Steven Tierney, Marcus Thompson, Maxim Shkunov, David Sparrowe, Iain McCulloch
-
Patent number: 6150379Abstract: The present invention relates to novel biheterocyclic derivatives which are factor Xa inhibitors; the pharmaceutically acceptable salts and N-oxides thereof; their uses as therapeutic agents and the methods of their making.Type: GrantFiled: November 17, 1998Date of Patent: November 21, 2000Assignee: Axys Pharmaceuticals, Inc.Inventors: Paul R. Fatheree, Thomas E. Jenkins, Martin S. Linsell, Sean G. Trapp, Erik J. Verner, Wendy B. Young
-
Patent number: 5770757Abstract: A catalyst having the atomic ratios set forth in the empirical formula below:A.sub.a B.sub.b C.sub.c Ge.sub.d Bi.sub.e Mo.sub..sub.12 O.sub.xwhereA=two or more of alkali metals, In and TlB=one or more of Mg, Mn, Ni, Co, Ca, Fe, Ce, Sm, Cr, Sb, and W; preferably B equals the combination of Fe and at least one element selected from the group consisting of Ni and Co and at least one element selected from the group consisting of Mg, Mn, Ca, Ce, Sn, Cr, Sb, and WC=one or more of Pb, Eu, B, Sn, Te and Cua=0.05 to 5.0b=5 to 12c=0 to 5.0d=0.1 to 2.0e=0.1 to 2.0x=the number of oxygen atoms required to satisfy the valency requirements of the other elements andb>a+c.Type: GrantFiled: May 3, 1996Date of Patent: June 23, 1998Assignee: The Standard Oil CompanyInventors: Tama Lee Drenski, Maria Strada Friedrich, Christos Paparizos, Michael J. Seely, Dev Dhanaraj Suresh
-
Patent number: 5468870Abstract: Dye-donor element for use according to thermal dye sublimation transfer comprising a support having thereon a dye layer containing a dye corresponding to the following formula ##STR1## wherein Z represents CN, COOR.sup.1 or CONR.sup.2 R.sup.3 ;R.sup.1, R.sup.2 and R.sup.3 each independently represent hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, or R.sup.2 and R.sup.3 together represent the necessary atoms to close a heterocyclic nucleus or substituted heterocyclic nucleus;Y represents OR.sup.4 or NR.sup.5 R.sup.6 or CN;R.sup.4 represents hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, SO.sub.2 R.sup.7, COR.sup.7, CSR.sup.7, POR.sup.7 R.sup.8 ;R.sup.5 and R.sup.6 each independently has one of the significances given to R.sup.4 or represent substituted or unsubstituted amino, or R.sup.5 and R.sup.Type: GrantFiled: October 20, 1994Date of Patent: November 21, 1995Assignee: AGFA-GAVAERT, N.V.Inventor: Luc J. Vanmaele
-
Patent number: 5466813Abstract: Imine dyes useful in photographic materials have the formula ##STR1## wherein R.sup.1, E.sup.1, E.sup.2, L.sup.1, L.sup.2, L.sup.3,D and m are defined as in the specification.Solid particle dispersions of dyes of formula (I) that contain at least one base-ionizable functional group such as carboxy, sulfonamido, or sulfamoyl are useful as filter dyes in photographic elements.Type: GrantFiled: July 20, 1993Date of Patent: November 14, 1995Assignee: Eastman Kodak CompanyInventors: Donald R. Diehl, Margaret J. Helber, Hugh Williamson
-
Patent number: 5142089Abstract: Dye corresponding to the following formula - ##STR1## wherein Z represents CN, COOR.sup.1 or CONR.sup.2 R.sup.3 ;R.sup.1, R.sup.2 and R.sup.3 each independently represents hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, or R.sup.2 and R.sup.3 together represent the necessary atoms to close a heterocyclic nucleus or substituted heterocyclic nucleus;Y represents OR.sup.4 or NR.sup.5 R.sup.6 or CN;R.sup.4 represents hydrogen, substituted or unsubstituted or unsubstituted aryl, SO.sub.2 R.sup.7, COR.sup.7, CSR.sup.7, POR.sup.7 R.sup.8 ;R.sup.5 and R.sup.6 each independently has one of the significances given to R.sup.4 or represents substituted or unsubstituted amino, or R.sup.5 and R.sup.6 together represent the necessary atoms to close a heterocyclic nucleus or substituted heterocyclic nucleus, including a heterocyclic nucleus with an aliphatic or aromatic ring fused-on;R.sup.7 and R.sup.Type: GrantFiled: June 4, 1991Date of Patent: August 25, 1992Assignee: Agfa-Gevaert, N.V.Inventor: Luc J. Vanmaele
-
Patent number: 4782073Abstract: The invention relates to novel amides of [(5,6-dichloro-3-oxo-9a-substituted-2,3,9,9a-tetrahydrofluoren-7-yl)oxy]ac etic acids, their derivatives, and their salts. The compounds are useful for the treatment and prevention of injury to the brain and of edema due to head trauma, stroke (particularly ischemic), arrested breathing, cardiac arrest, Reye's syndrome, cerebral thrombosis, cerebral embolism, the neurological problems caused by AIDS, cerebral hemorrhage, cerebral tumors, encephalomyelitis, spinal cord injury, hydroephalus, post-operative brain injury trauma, edema due to cerebral infections, various brain concussions and elevated intracranial pressure.Type: GrantFiled: December 24, 1986Date of Patent: November 1, 1988Assignee: Merck & Co., Inc.Inventor: Edward J. Cragoe, Jr.
-
Patent number: 4728665Abstract: An amide derivative of the formula (I): ##STR1## or a tautomeric form thereof, wherein R is a phenyl group substituted in the 4-position by a group of R.sup.1 XCH.sub.2-, where R.sup.1 is C.sub.1 -C.sub.4 alkyl, C.sub.3 -C.sub.4 alkenyl, C.sub.3 -C.sub.4 alkynyl, C.sub.1 -C.sub.4 alkylcarbonyl, or H, and X is oxygen or sulphur;E is CN, or CSNH.sub.2, or CONH.sub.2 ; andY is 1-pyrazolyl or 2-furyl. Compositions and processes for using these derivatives to combat plant fungi are also disclosed.Type: GrantFiled: August 23, 1985Date of Patent: March 1, 1988Assignee: Imperial Chemical Industries PLCInventors: Margaret C. Shephard, Patrick J. Crowley